Soliqua 100/33 Injection, Solution
Product Images NDC 0024-5761

25 FDA label images from Sanofi-aventis U.s. Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Soliqua 100/33 (NDC 0024-5761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 01)

Figure 1 (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 01)
A line graph comparing the mean percentage values over several weeks for three different treatments labeled INS/LIXI, INS, and LIXI. The x-axis represents weeks, and the y-axis shows the mean percentage ranging approximately from 6.0% to 9.0%. The chart includes a legend identifying the three treatment groups with distinct markers and colors, along with the number of subjects per treatment group listed below the x-axis.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 02)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 02)
An instructional diagram illustrating recommended subcutaneous injection sites for Soliqua 100/33 injection. Highlighted areas in green include the upper arms, stomach, and thighs on a human figure, indicating appropriate locations for administration.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 03)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 03)
An instructional diagram of the Soliqua 100/33 injection pen, showing labeled parts including the pen cap, cartridge holder, rubber seal, medicine scale, plunger, medicine name label, expiration date location, dose window, dose pointer, dose selector, and injection button.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 04)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 04)
The image shows a Soliqua 100/33 injection pen label for subcutaneous use. The label displays the product name Soliqua 100/33 containing insulin glargine and lixisenatide. It highlights 'For Single Patient Use Only' with strengths 100 units/mL and 33 mcg/mL, manufactured by Sanofi-Aventis U.S. LLC.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 05)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 05)
An instructional illustration showing how to remove the cap from a Soliqua 100/33 injection pen. The left side shows a hand holding the pen with the cap on, and the right side shows the hand pulling the cap off the pen, indicated by a blue arrow pointing to the right.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 06)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 06)
Soliqua 100/33 injection, solution for subcutaneous use, containing insulin glargine and lixisenatide at strengths of 100 units/mL and 33 mcg/mL. The image shows a close-up of the product's dose window and part of the label indicating it is for single patient use only. The labeler is Sanofi-Aventis U.S. LLC.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 07)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 07)
An instructional illustration depicting a person cleaning the rubber stopper of a syringe with a cloth or wipe prior to administering an injection. The syringe is held in one hand, and the wiping action is performed with the other hand, focusing on aseptic technique for injection preparation.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 08)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 08)
An instructional line drawing showing hands assembling or attaching a component of a medical injection device, likely related to the subcutaneous injection of Soliqua 100/33 (insulin glargine and lixisenatide). The illustration focuses on the interaction between the hands and the device parts.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 09)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 09)
An instructional diagram showing how to remove a protective cap from a Soliqua 100/33 injection pen. Illustrations depict two hands holding the pen and cap, with arrows indicating the motion to twist and pull off the cap before use.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 10)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 10)
An instructional diagram showing a hand holding a Soliqua 100/33 prefilled pen injector and another hand removing the protective cap from the pen needle, demonstrating preparation for subcutaneous injection.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 11)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 11)
An instructional illustration showing a hand removing a cap from a vial while another hand holds an injection pen angled toward the vial opening, suggesting preparation for drawing medication or administering an injection.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 12)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 12)
An instructional illustration showing hands holding a Soliqua 100/33 injection pen. The image highlights a close-up of the dose selector window on the pen, indicating the halfway (1/2) dose mark. It depicts a hand rotating the dose knob on the pen, suggesting dose adjustment by turning the knob upward.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 13)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 13)
An instructional diagram showing hands priming a syringe by pushing liquid through the needle, with a close-up inset illustrating fluid exiting the needle tip.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 14)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 14)
An instructional illustration depicting a hand preparing the Soliqua 100/33 injection pen for subcutaneous injection. The image focuses on the pen's dosing window displaying dose '15' and the end cap being removed by the thumb and forefinger, highlighting part of the injection device operation.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 15)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 15)
Soliqua 100/33 injection solution in a prefilled pen device for subcutaneous use. The label on the pen shows the product name Soliqua 100/33, containing insulin glargine and lixisenatide, with directions for single patient use only. The pen features a dosage scale with markings for measurement and a protective cap.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 16)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 16)
An illustration showing the dose selection window on an injectable pen device. Visible numbers on the dose dial are 28, 30, and 32, indicating dose increments for injection dose adjustments.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 17)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 17)
An instructional diagram showing a close-up of the dosing selector on a Soliqua 100/33 injection device. The dial displays the dose range from 28 to 30 units, indicating how the dose can be adjusted for subcutaneous injection.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 18)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 18)
An illustration showing a hand holding a Soliqua 100/33 injection pen. The pen is positioned for subcutaneous injection with an arrow indicating the injection direction away from the body surface.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 19)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 19)
An instructional illustration showing how to properly remove the cap from a Soliqua 100/33 injection pen. It depicts a hand gripping the pen and twisting the cap in the direction indicated by an arrow. A close-up highlights the correct method of twisting the cap without pinching it, with a red circle and line indicating the incorrect way to hold the cap.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 20)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 20)
An instructional illustration showing a hand holding a Soliqua 100/33 injection pen. The image highlights the step of pressing the injection button and holding it for 10 seconds, indicated by a clock symbol, to ensure complete delivery of the medication.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 21)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 21)
An instructional diagram showing hands holding a Soliqua 100/33 injection pen, demonstrating the removal of the pen cap by pulling it straight off. The image focuses on proper handling technique before subcutaneous injection.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 22)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 22)
An instructional illustration showing the correct way to remove the cap from a Soliqua 100/33 injection pen. Two hands are depicted, with arrows indicating the steps to twist and pull the cap off the pen device to prepare it for use.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 23)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 23)
An instructional illustration showing a pair of hands removing the cap from a small vial or container. The left hand holds the container steady while the right hand lifts off a cap, indicated by a blue curved arrow showing the motion of removing the cap upward.*
FDA Label Image

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 24)

Image (4bba538b Cf7c 4310 Ae8f Cb711ed21bcc 24)
Illustration showing how to remove the cap from the Soliqua 100/33 pen injector prior to use. The image depicts hands holding the pen and pulling the cap off with an arrow indicating the direction to remove the cap.*
FDA Label Image

Principal Display Panel (3 mL Pen Carton)

Principal Display Panel (3 mL Pen Carton)
The packaging label for Soliqua 100/33 injection shows it contains insulin glargine and lixisenatide, with strengths of 100 units/mL and 33 mcg/mL respectively. It is a subcutaneous injection for single patient use only, supplied in five 3 mL prefilled pens (15 mL total). The label specifies storage instructions, dosing notes, and that needles are not included. The labeler is Sanofi-Aventis U.S. LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.